ENGN•businesswire•
enGene to Participate in the Guggenheim Emerging Outlook: Biotech Summit 2026
Summary
BOSTON & MONTREAL--(BUSINESS WIRE)--enGene Holdings Inc. (Nasdaq: ENGN or “enGene”), a clinical-stage, non-viral genetic medicines company, today announced that Ron Cooper, President and Chief Executive Officer, will participate in a fireside chat at the Guggenheim Emerging Outlook: Biotech Summit 2026 on Wednesday, February 11, 2026, at 2:30 p.m. ET. A live webcast of the fireside chat can be accessed on the "Events and Presentations” page under the “Investors” section of the enGene website at
Original Article
Read the full article from the original source for complete details and context.
Read Full ArticleArticle published on February 4, 2026 by businesswire